Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 14

Empagliflozin Regulates the AdipoR1/p-AMPK/p-ACC Pathway to Alleviate Lipid Deposition in Diabetic Nephropathy

Total article views   HTML views PDF downloads Totals
8,003 Dovepress* 6,786+ 954 7,740
PubMed Central* 1,217 442 1,659
Totals 8,003 1,396 9,399
*Since 18 January 2021
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 1 3

View citations on PubMed Central and Google Scholar